BEX1 and hypertrophic cardiomyopathy: Moreover, BEX1 upregulation was associated with “pantothenate and coa biosynthesis”, “homologous rcombination” and “propanoate metabolism,” whereas its downregulation may activate “arrhythmogenic right ventricular cadiomyopathy”, “dilated cardiomypathy”, “glycosaminoglycan biosythesis keratan sulfate”, “hypertrophic cardiomyopathy”, “WNT signaling pathway” “NOTCH signaling pathway” and “basal cell carcinoma”.